Viltepso® (viltolarsen)
| Full Name | Viltepso® (viltolarsen) |
| Drug | Viltepso |
| Manufacturer | NS Pharma |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping |
| Disease | Duchenne Muscular Dystrophy (DMD) |
| Therapeutic Area | Neurology |
| Enrollment Form Link | Viltepso Enrollment Form |
| Phone Number | 800-759-0445 |
| Fax Number | 877-286-3620 |
| Product Website | viltepso.com |
| Patient Resources | Alex Rezcalla Foundation, Jett Foundation, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy |